In a triumph for its unwavering commitment to excellence in logistics and supply chain management, FedEx Express (FedEx), a subsidiary of FedEx Corp. and a global leader in express transportation services, has clinched the prestigious title of “Overall Logistics & Supply Chain Management Supplier of the Year” at the Asia-Pacific Biopharma Excellence Awards 2024 (ABEA 2024). The company has also been honored with the “Best Logistics & Supply Chain Management Supplier Award: Last Mile Implementation” at the same event.
The ABEA 2024, orchestrated by IMAPAC, aims to spotlight exceptional achievements in bioprocessing, logistics, supply chain management, and clinical trials expertise within the Asian region. This recognition underscores FedEx’s steadfast dedication to elevating standards within the healthcare logistics sphere.
“The healthcare industry has very specific and carefully regulated logistics needs. Being recognized by voters among the biopharma community is the highest possible recognition we can receive. Our mission is to make supply chains smarter for everyone. We are transforming to build the world’s most flexible, efficient, and intelligent logistics network by using advanced sensor-based monitoring and predictive tools to ensure critical shipments reach their destinations safely. Our healthcare customers can be confident our innovative solutions will meet all their shipping needs,” according to Salil Chari, Senior Vice-President, Marketing and Customer Experience, Asia Pacific, Middle East, and Africa Region at FedEx Express.
Over the years, FedEx has meticulously cultivated its healthcare capabilities, boasting a specialized healthcare team and an expansive cold chain network, facilitating the transportation of vaccines, biologics, and medical supplies across the globe. With an extensive global network comprising over 680 aircraft and 200,000 vehicles, and the presence of four Life Science Centers strategically located in South Korea, Japan, Singapore, and India, FedEx has emerged as a pivotal player in ensuring the seamless movement of healthcare shipments. Leveraging temperature-controlled solutions and real-time monitoring via FedEx SenseAware, the company prioritizes shipment integrity, thereby safeguarding the efficacy of critical medical cargo.
FedEx’s bespoke service, FedEx Clinical Care, offers an end-to-end shipping solution tailored to transport delicate biological samples with precision, ensuring compliance with stringent clinical trial requirements.
The ABEA 2024, held in conjunction with the 11th Biologics Manufacturing Asia, 8th BioLogistics World Asia, and 2nd Clinical Trials Festival Asia, brought together a multitude of luminaries from the biopharma industry, fostering knowledge exchange and collaboration.